Lu Daopei Hematology and Oncology Center was renamed Heibei Yanda Lu Daopei Hospital
CAR-T technology was adopted in the treatment of B-cell acute lymphoblastic leukemia (B-ALL), lymphoma, multiple myeloma and other malignant blood diseases in July 2015.
The 3rd Lu Daopei Hematology Summit Forum
In June 2015, the third Lu Daopei Hematology Summit Forum was held at Beijing International Conference Center, with nearly 500 participants. The forum consisted of two parts: "Academic Exchange" and "Charity Banquet". The former was themed on the development and prospects of precision treatment for blood diseases, and the latter was themed on "Charity Banquet of V LoveFund on Leukemia ".